about
Genome-wide association study identifies new prostate cancer susceptibility lociA genome-wide search for loci interacting with known prostate cancer risk-associated genetic variantsInherited genetic variant predisposes to aggressive but not indolent prostate cancer.Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsCharacterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk predictionA genetic-based approach to personalized prostate cancer screening and treatment.Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examinationValidation of genome-wide prostate cancer associations in men of African descent.Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans.Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Genome-wide two-locus epistasis scans in prostate cancer using two European populationsUsing graded response model for the prediction of prostate cancer risk.Prostate cancer risk-associated genetic markers and their potential clinical utilityA genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.Prostate cancer risk associated loci in African Americans.Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.Comprehensive functional annotation of 77 prostate cancer risk loci.Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.Early detection of prostate cancer with emphasis on genetic markers.Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene.
P2860
Q28924380-0AFBFDDF-C25B-440D-B8FB-76FE2BFCBFA6Q28943269-79D6D252-E9AF-4999-903F-C41CC05BFB9FQ33719967-56C5C1D7-276C-4751-82F2-A3DE769BD82CQ33782243-7CD62FED-9545-4526-8EC6-5F09CB13A5F1Q33842251-60BD76A9-E8D2-4784-A104-68F893697BB2Q34454426-5425F137-6F9E-4F8E-9F14-93638C4C59F0Q34661857-264A6980-40BA-4175-8328-D3E05905FDD2Q34802764-4540F54E-1DB5-4E9F-A8BF-253D7BA1FA95Q34946649-BB9CBA4D-8638-49AD-BD2D-9C5E8FE95F84Q35032730-435061BD-E16D-4E7A-B719-80BC7B517221Q35478990-FAFDB336-1223-488A-80D3-6FB95992D50BQ35535768-9B48A3FC-A002-4D4D-9340-53E0F5ABB39DQ35711202-A718CEE1-71A5-462D-8170-4BB0C13D00CEQ36005195-51241F6A-5CDE-4E28-9F26-AA052C7C740DQ36100579-A28CCE0B-3BC7-4870-AEA3-AC455775569CQ36477652-A41EDEFF-51C4-4213-AE7D-E1E77660011EQ36790692-07D0678D-B8CE-411D-A28E-24100C92D528Q37074047-B71FA4AE-55B3-4D8C-99C7-C8546C810CE4Q37085446-62319CD6-0FE5-4047-AAFF-287D9EE9696BQ37225298-AFC4D64A-33C9-4528-9E6F-A5BC1A443B2CQ37312769-4A33E3E3-C184-48A5-B143-4D6DE5566ABCQ37474516-AA895C2E-F3B5-4C6A-8342-A6BB9A4F1500Q37533894-CEFB2294-9758-41CD-B599-F848167378FDQ37541989-767B57B4-2221-4D51-8987-64136290712AQ37592171-712E48C9-D8B9-4593-B7B1-A53D1941C58AQ37878464-38D60153-F3ED-4626-AD3B-F23DBF95FDAEQ38275010-1BCFE3A0-020D-4458-90F3-148BEA9B0725Q38503798-E96A29D8-162D-4D8C-A617-6EFF4D30E29DQ39141778-1D4CE315-C1DD-4BDE-BAA8-A2AF110D7181Q39852672-80370A58-5CAF-4CD6-BBC0-7AAF690E8661Q40311743-FBDFE4E2-3E78-497F-B27F-43804CD513AEQ46319738-402D4671-88C5-4C16-A858-C24FC4C7225B
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A novel prostate cancer susceptibility locus at 19q13
@ast
A novel prostate cancer susceptibility locus at 19q13
@en
A novel prostate cancer susceptibility locus at 19q13.
@nl
type
label
A novel prostate cancer susceptibility locus at 19q13
@ast
A novel prostate cancer susceptibility locus at 19q13
@en
A novel prostate cancer susceptibility locus at 19q13.
@nl
prefLabel
A novel prostate cancer susceptibility locus at 19q13
@ast
A novel prostate cancer susceptibility locus at 19q13
@en
A novel prostate cancer susceptibility locus at 19q13.
@nl
P2093
P2860
P50
P1433
P1476
A novel prostate cancer susceptibility locus at 19q13
@en
P2093
Bao-Li Chang
David Duggan
Fang-Chi Hsu
Fredrik Wiklund
Jielin Sun
John D Carpten
Kathleen E Wiley
Lina D Purcell
Patrick C Walsh
Pär Stattin
P2860
P304
P356
10.1158/0008-5472.CAN-08-3347
P407
P577
2009-03-24T00:00:00Z